Ionis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
IONS Key Statistics
Stock Snapshot
As of today, Ionis Pharmaceuticals(IONS) shares are valued at $71.55. The company's market cap stands at 11.59B, with a P/E ratio of -41.81.
On 2025-11-15, Ionis Pharmaceuticals(IONS) stock moved within a range of $68.90 to $72.54. With shares now at $71.55, the stock is trading +3.8% above its intraday low and -1.4% below the session's peak.
Trading activity shows a volume of 3.33M, compared to an average daily volume of 3.79M.
The stock's 52-week range extends from a low of $23.95 to a high of $76.78.
The stock's 52-week range extends from a low of $23.95 to a high of $76.78.
IONS News
Ionis Pharmaceuticals (IONS) and Otsuka Pharmaceutical announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has ad...
Ionis Pharmaceuticals recently announced positive results from its pivotal Phase 3 CORE and CORE2 studies of olezarsen in severe hypertriglyceridemia, with the...
...
Analyst ratings
72%
of 25 ratingsMore IONS News
Michael Ulz, an analyst from Morgan Stanley, reiterated the Buy rating on Ionis Pharmaceuticals. The associated price target remains the same with $94.00. Meet...
(RTTNews) - Ionis Pharmaceuticals Inc. (IONS) announced positive results from its pivotal Phase 3 CORE and CORE2 studies evaluating olezarsen in patients with s...
